In this online CME self-learning program:
Effective glucose control in the intensive care unit (ICU) has been shown to decrease morbidity across a large range of conditions and also to decrease mortality. Establishing a working glycemic control policy in the ICU is challenging as there are concerns regarding inducing hypoglycemia, nurse workload issues, and questions as to the optimal glucose range to manage the patient to. With 7.8% of the U.S. population having diabetes and 38% of patients being admitted to hospitals having hyperglycemia, this is a significant problem. In addition, recent research has shown a decrease in mortality if there is less variability in the glucose values. This session will provide an interactive approach to discuss the questions; How tight should tight be?, Is it tight versus timing?, and is it patient driven glucose control or clock driven control?
Agenda
This program has been designed for a multidisciplinary physician and nurse audience treating patients in the ICU and other critical care environments, including: ICU / Anesthesia / Peri-op / Intensivists / Trauma / Critical Care
This program is supported by an educational grant from Edwards Lifesciences, a manufacturer of Medical Devices.
Examples of glycemic protocols
Based upon participant feedback, the following links have been provided to show examples of different institutions' glycemic protocols:
Northwestern Memorial Hospital, Chicago, IL, USA
Release Date: August 20, 2011 -- Expiration Date: August 20, 2014
Faculty: Barbara 'Bobbi' Leeper, MN, RN, CNS, CCRN
By the end of the session the participant will be able to:
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through ScientiaCME. ScientiaCME is accredited by the ACCME to provide continuing medical education for physicians.
ACCREDITATION FOR THIS COURSE HAS EXPIRED. YOU MAY VIEW THE PROGRAM, BUT CME / CE IS NO LONGER AVAILABLE AND NO CERTIFICATE WILL BE ISSUED.
As an provider of continuing medical education, it is the policy of the ScientiaCME to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, faculty and educational planners must disclose any significant relationships with commercial interests whose products or devices may be mentioned in faculty presentations, and any relationships with the commercial supporter of the activity. The intent of this disclosure is to provide the intended audience with information on which they can make their own judgments. Additionally, in the event a conflict of interest (COI) does exist, it is our policy to ensure that the COI is resolved in order to ensure the integrity of the CME activity. For this CME activity, any COI has been resolved through content review by ScientiaCME.
Faculty Disclosure: Barbara "Bobbi" Leeper, RN discloses receiving consulting income from Edwards Lifesciences.
Disclosures of Educational Planners:
Steven Sachse is an officer and part owner of ScientiaCME, LLC, which has received a grant from the commercial supporter of this program: Edwards Lifesciences.
Charles Turck, PharmD, is an officer and part owner of ScientiaCME, LLC, which has received a grant from the commercial supporter of this program: Edwards Lifesciences.
Commercial Support Disclosure: This program is supported by an educational grant from Edwards Lifesciences, a manufacturer of medical devices.
*Required to view Printable PDF Version
Please take a few minutes to participate in the optional pre-test. It will help us measure the knowledge gained by participating in this activity.